Fluorescent microspheres were used to measure antibody-induced capping of leukocyte membrane proteins that are immun ologically related to band 3, the anion exchanger of the erythrocyte. The degree of capping was found to increase with donor age. Surface labeling and capping characteristics of cells from healthy, age-matched controls were not different from those from patients with Alzheimer's disease, multi-infarct dementia, and Down's syndrome. Immunoblots, however, indicated increased expression and/or breakdown of band 3-like proteins in leukocytes from patients when compared with young and old control donors. These findings emphasize the possible involvement of band 3-like proteins of nucleated cells in aging and disease.
Introduction
During the last few years, it has become clear that band 3, the anion transporter of the human erythrocyte, belongs to the gene family of anion exchanger proteins [1, 2] . The various members of this family presently known (AE1 or band 3, AE2, AE3) have been described to be expressed in many different cells and tissues, including white blood cells [1, 2] . The AE proteins share extensive structural homology in their membrane domain and, in agreement with the exclusive involve ment of the membrane domain of AE1 in chloride/bicarbonate exchange, they all seem to play a role in anion exchange-based regulation of intracellular pH [3, 4] . The cytoplasmic domains of the AE members show considerable diversity, possibly reflecting their tissue-specific interaction with intracellular elements such as the cytoskeleton [1 ,2] .
In addition to anion transport and providing an anchor site for the cytoskeleton, AE1 plays a pivotal role in erythrocyte aging (for a recent review, see [5] ). Age-dependent changes in AE1 conformation result in the appearance of a neo antigen, leading to recognition and removal of old cells by the immune system. The mechanism that underlies these age-related changes in AE1, and that may also be active in other cell types, seems to be altered in various diseases, including Alzheimer's disease [5] [6] [7] [8] . Aging-and disease-related changes in AE1 structure affect anion transport as well as interaction of AE1 with the cytoskeleton [5] , The capping behaviour of surface receptors, i.e. their aggregation within the plasma membrane upon binding of an external agent such as an antibody, may indicate, among other things, the strength of their association with the cytoskeleton [9] .
It occurred to us that aging-and disease-related changes in capping behaviour of AE proteins might identify aging-and/or disease-related, structural alterations. Therefore, in the course of our studies on the involvement of AE proteins in normal and pathological aging [6, 7] , we investigated the effect of normal aging on capping of band 3-like (AE) molecules in white blood ceils. We compared the capping characteristics of band 3-like proteins in white blood cells from young and old control donors with those of patients with Alzheimer-like dementia (AD), of patients with multi-infarct dementia (MID), and of individuals with Down's syndrome (DS). For this purpose we adapted a method to visualize antigens with fluorescent microspheres [10] in order to visualize antibody-induced capping.
In this report we describe an age-dependent increase in band 3 capping in leukocytes, as well as an apparent increase in breakdown of band 3-like proteins in the leukocyte fraction of the patient donor groups.
Materials and methods

Patients
Patients with the diagnosis dementia of the Alzheimer-type (AD, 81 + 5 years, n = 8) and multi-infarct dementia (MID, 82 ± 4 years, n = 8) were from a local psycho geriatric institution. Young controls (YC, 29 + 5 years, n = 8) were laboratory coworkers, and old, healthy controls (OC, 82 + 5 years, n = 8) were from two local homes for the elderly. Down's syndrome patients (DS, non-demented 26 ± 3 years, n = 3; demented, 60 years, n -2) were from an institution for the mentally handicapped. The diagnostic criteria used for selection of the various patient and control groups, as well as their clinical data have been described before [6, [11] [12] [13] . None of the donors had any immunological disorders, or used medica tions known to affect the immune system [6] ,
Nucleated blood cell isolation
Blood was collected with EDTA as anticoagulant, and nucleated blood cells were isolated using a Ficoll-Paque gradient (Pharmacia LKB Biotechnology, Inc., Piscataway, NJ) as described before [6] . The viability of the various preparations was at least 95% as indicated by the ability of the cells to exclude trypan blue,
Anti-band 3 antibodies
Anti-band 3 antibodies (PM1B3) were raised in rabbits against the membrane domain of human erythrocyte band 3. Their immunoreactivity pattern with ery throcyte band 3 has been described before [13] . Lymphocytes (4 x 105 cells) were incubated with rabbit anti-hum an band 3 antiserum PM 1B3, diluted (1:4000) with phosphate-buffered saline/1% bovine serum album in (PBS/BSA) for 15 min at 37°C. After this period, cells were washed four times with ice-cold PBS/BSA by centrifugation (100 x g x 5 min), and fixed with form aldehyde (pH 7.0; 0.025% in PBS) for 30 min at 18°C. Labeling of fluorescent microspheres (Covaspheres M X , D uke Scientific Co., Palo Alto, CA) with swine-anti rabbit IgG, and labeling of the cells with the coated microspheres were perform ed exactly as described before [10] . The final cell pellet was resus pended in 15 //I PBS/BSA, and 100-200 cells were evaluated at 400 x magnifica tion under a fluorescence microscope as in [10] . Cells were grouped into four categories: lacking any microspheres, completely covered with microspheres, n o n capping (the -individually visible -microspheres were evenly distributed on the cell surface), and capping (the fluorescence was restricted to less than one half of the cell surface [14,15] ( Fig. 1 ). Capping characteristics were determ ined by one of us (B,D*S.), who had no previous inform ation of the clinical d ata of the donors.
Blanks consisting o f preserum resulted in less than 2% labeled cells.
Immunoblot analysis
H om ogenates of nucleated blood cells were prepared following the procedure of [16] , and analyzed by im m unoblotting as described before [7] , using the same antiserum that was used for the capping studies (PM1B3, 1:500, [13]). All lanes contained the same am ount of protein (10 ¡.ig).
Results
Capping assay conditions
A ntibody dilutions resulting in labeling of the highest percentage of cells ('m axi mal labeling5), and incubation time and tem perature resulting in the highest num ber of labeled cells showing capping ('maximal capping5), were determ ined using white blood cell preparations from young control donors. Optimal antibody dilutions were determ ined by combinations of serial dilutions (1:100-1:20 000 final dilution) o f the rabbit anti-band 3 antiserum PM1B3 and swine-anti rabbit IgG (SAR), and the highest dilutions still yielding maximal labeling were used. These dilutions were 1:4500 for PM 1B3 and 1:4000 for SAR. The m ean maximal percentage o f labeled cells was 64 ± 11% (range, 50-85% ; n = 7). Variation of incubation time and tem perature showed that capping was temperature-dependent; the highest percent age o f capping cells (32 ± 3%; range 26-37% ; n -7) was reached after 15 m in at 37°C.
Aging-related capping
The num ber of cells that were n o t labeled with the anti-band 3 antiserum did not differ between the various donor groups (30-40% ; Table 1 ). There also was no significant difference between the donor groups in the fraction of cells th at were labeled with the antiserum, but that displayed no capping, with the exception o f the " White blood cells were labeled with anti-erythrocyte band 3 antiserum, and the degree of capping was determined with fluorescent microspheres as described in the Materials and methods section. Values represent percentages of total cells. The number of donors that was measured in one group is given in parentheses. The fraction 'Labeled without capping' also contains the cells fully covered with microspheres (see also the Materials and methods section).
* Significantly different (P < 0.01) from the value of YC. ** Significantly different (P < 0.05) from the value of DS.
DS group (Table 1 ). In the DS group, the fraction of capping refractory cells was significantly higher than those of the Alzheimer and M ID groups (P < 0.05), but especially higher than that of the old control group (P < 0.001). There were no notable differences between the young (26 years) and old (60 years) DS donors. The most striking finding of the capping studies is that in the white blood cells that were labeled with the anti-band 3 antiserum, capping of band 3-like molecules in the plasma membrane increases with donor age. The fraction of cells that showed capping was significantly increased in the older donors when compared with the young controls (Table 1 ). There was a significant positive correlation between donor age and percentage of cells with capping (r = 0.87; P<0.01), We did not observe any Alzheimer-specific changes in capping of band 3-like molecules in white blood cells from Alzheimer patients; there were no significant differences between the AD patients, the MID patients, and the age-matched (old) control group (Table   1 ). It is noteworthy that the fraction of capping cells in the DS group was similar to that of the young control group, and also significantly smaller than that found in the AD, MID, and OC groups ( Table 1) .
Immunoblots
The white blood cell proteins from the same donor groups used in the capping analysis, were analyzed on immunoblots with the same antiserum against the membrane domain of erythrocyte band 3 that was used for the capping studies. In addition to the expected reaction of this antiserum with proteins in the 95-to 110-kDa molecular weight region of intact band 3, all fractions contained immunoreactive proteins of smaller apparent molecular weights (Fig. 2) . These smaller polypeptides arise either by breakdown of the native proteins, or may represent incomplete molecules [1, 8] . Initial analysis indicated the presence of an anti-band 3 immunoreactive polypeptide with an apparent molecular weight of ~ 40 kDa in Alzheimer patients, but not in young and age-matched control donors. More extensive analysis, however, showed the presence of this polypeptide in the cells from all donors with pathology, but its almost complete absence in the white blood cells of young and old controls (Fig. 2) . Also, the fractions of the patient groups seem to contain more proteins in the higher molecular weight regions. These differences were only observed with antibodies raised against the membrane domain of AE1, and not with antibodies specific for AE2 (data not shown).
Discussion
Detection of surface molecules on intact cells using fluorescent microspheres has several advantages compared with classical methods: a high sensitivity, a high i signal/noise ratio, and (from a practical viewpoint) resistance against bleaching, and no need for dark room conditions for evaluation and quantification. One of us already demonstrated the potential of fluorescent microspheres for detection of very early erythrocyte chimaerism in patients with bone marrow transplants [10] . Here we have successfully applied fluorescent microspheres to the measurement of antibody-induced capping in nucleated blood cells.
Polypeptides of the AE family related to band 3 and senescent cell antigen are present in white blood cells [17] [18] [19] . At present the exact identity of these proteins and their distribution over the various cell types is not clear, but our preliminary immunochemical and RNA typing indicate that both AE1 and AE2 are expressed in white blood cells [19], Capping of band 3-like molecules in white blood cells has been described before [17, 18] , and we show here that the extent of capping increases with increasing donor age, This is in sharp contrast with the age-related decrease of capping of other membrane receptors in white blood cells [14] . The increase in anti-band 3-induced capping seems to be related only to age, and showed no pathological component; we observed no differences in capping between the old controls and the (old) patient groups. This indicates that the process(es) responsible for this increase, through changes either in band 3-like molecules or in cytoskeleton proteins, is (are) not visibly affected in Alzheimer's disease. Changes in actin molecules of white blood cells, that play an important role in receptor capping [9] , or in other components of the cytoskeleton in neurons, have been reported for Alzheimer patients [8, 20] . It cannot be excluded that various Alzheimer-related changes have counteractive effects on the capping behaviour of AE proteins, resulting in overall identical capping behaviour in aged controls and AD patients, but at present we must conclude that capping of band 3-like molecules in the plasma membrane of white blood cells is not affected by Alzheimer's disease.
One explanation for increased mobility of band 3-like molecules within the membrane may be proteolytic breakdown, resulting in a decreased interaction with the cytoskeleton. Age-and disease-related breakdown of band 3 probably plays a pivotal role in the mechanism that leads to recognition and removal of old Age-and Alzheimer-related changes in structure and function o f AE proteins have recently been described in erythrocytes, as well as in neurons [6, 7] . The data we present here provide further support for the hypothesis that molecular charac terization of the aging-related changes in band 3-like (AE) proteins may illuminate the mechanism(s) and consequences of normal cellular aging and degeneration [8, 25] . This may be o f broader relevance in view of the putative function o f band 3-like proteins in immune cells [26, 27] , and o f the changes in immunological parameters, which occur during normal aging and in patients with Alzheimer's disease [21,23,28,29],
